Safety, Efficacy, and Determination of the Recommended Phase 2 Dose for the Oral Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330)

被引：0

作者：

Chen, Christine ^{[1
]}

Garzon, Ramiro ^{[2
]}

Gutierrez, Martin ^{[3
]}

Jacoby, Meagan A. ^{[4
]}

Brown, Peter ^{[5
]}

Flinn, Ian ^{[6
]}

Stone, Richard M. ^{[7
]}

Savoie, Mary Lynn ^{[8
]}

Baz, Rachid ^{[9
]}

Gabrail, Nashat Y. ^{[10
]}

Wang, Michael ^{[11
]}

Martin, Peter ^{[12
]}

Siegel, David ^{[13
]}

Mau-Sorensen, Morten ^{[5
]}

Andreef, Michael ^{[14
]}

Marshall, Tracey ^{[15
]}

Saint-Martin, Jean-Richard ^{[15
]}

Carlson, Robert ^{[15
]}

Shacham, Sharon ^{[16
]}

Kauffman, Michael ^{[15
]}

Kuruvilla, John ^{[17
]}

机构：

[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[2] Ohio State Univ, Columbus, OH 43210 USA

[3] John Theurer Canc Ctr, Hackensack, NJ USA

[4] Washington Univ, Dept Med, Div Oncol, St Louis, MO USA

[5] Univ Copenhagen Hosp, Rigshosp, DK-2100 Copenhagen, Denmark

[6] Sarah Cannon Res Inst, Nashville, TN USA

[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[8] Univ Calgary, Calgary, AB, Canada

[9] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA

[10] Gabrail Canc Ctr, Canton, OH USA

[11] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[12] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA

[13] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[15] Karyopharm Therapeut, Newton, MA USA

[16] Karyopharm Therapeut Inc, Newton, MA USA

[17] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
Abbey R. Sadowski
Heather L. Gardner
Antonella Borgatti
Heather Wilson
David M. Vail
Joshua Lachowicz
Christina Manley
Avenelle Turner
Mary K. Klein
Angharad Waite
Alexandra Sahora
Cheryl A. London
BMC Veterinary Research, 14
[42] The efficacy of selinexor (KPT-330), an XPO1 inhibitor, on non-hematologic cancers: a comprehensive review
Jennifer R. Landes
Stephen A. Moore
Brooke R. Bartley
Hung Q. Doan
Peter L. Rady
Stephen K. Tyring
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2139 - 2155
[43] Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma
Sadowski, Abbey R.
Gardner, Heather L.
Borgatti, Antonella
Wilson, Heather
Vail, David M.
Lachowicz, Joshua
Manley, Christina
Turner, Avenelle
Klein, Mary K.
Waite, Angharad
Sahora, Alexandra
London, Cheryl A.
BMC VETERINARY RESEARCH, 2018, 14
[44] Effect of selinexor (KPT-330), a novel oral selective inhibitor of nuclear export (SINE), on tumor suppressors and cell cycle proteins in prostate cancer cells and regression of castration-resistant patient-derived xenograft tumor growth.
Maity, Sankar N.
Wu, Guanglin
Lu, Jing-Fang
Anh Hoang
Landesman, Yosef
McCauley, Dilara
Carlson, Robert
Rashal, Tami
Shacham, Sharon
Broom, Bradley McIntosh
Baggerly, Keith A.
Aparicio, Ana
Efstathiou, Eleni
Araujo, John C.
Logothetis, Christopher
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
[45] Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Of a First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin's Lyphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Kuruvilla, John
Gutierrez, Martin
Shah, Bijal D.
Gabrail, Nashat Y.
Brown, Peter de Nully
Stone, Richard M.
Garzon, Ramiro
Savona, Michael
Siegel, David S.
Baz, Rachid
Mau-Sorensen, Morten
Davids, Matthew S.
Byrd, John C.
Shacham, Sharon
Rashal, Tami
Yau, Cindy Y. F.
McCauley, Dilara
Saint-Martin, Jean-Richard
McCartney, John
Landesman, Yosef
Klebanov, Boris
Pond, Greg
Oza, Amit M.
Kauffman, Michael
Mirza, Mansoor R.
BLOOD, 2013, 122 (21)
[46] Selinexor, a selective inhibitor of nuclear export (SINE), in patients with unresectable melanoma.
Kendra, Kari Lynn
Watson, Ryan
Lesinski, Gregory B.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[47] Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom's Macroglobulinemia (WM)
Chen, Christine I.
Gutierrez, Martin
Brown, Peter de Nully
Gabrail, Nashat
Baz, Rachid
Reece, Donna E.
Savona, Michael
Trudel, Suzanne
Siegel, David S.
Mau-Sorensen, Morten
Kuruvilla, John
Byrd, John C.
Shacham, Sharon
Rashal, Tami
Yau, Cindy Y. F.
McCauley, Dilara
Landesman, Yosef
Klebanov, Boris
Pond, Greg
Oza, Amit M.
Kauffman, Michael
Mirza, Mansoor R.
BLOOD, 2013, 122 (21)
[48] Nuclear Export Inhibition for Radiosensitization: A Proof-of-Concept Phase 1 Clinical Trial of Selinexor (KPT-330) Combined With Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
Lawrence, Yaacov R.
Shacham-Shmueli, Einat
Yarom, Nirit
Khaikin, Marat
Venturero, Moris
Apter, Sara
Inbar, Yael
Symon, Zvi
Aderka, Dan
Halpern, Naama
Berger, Raanan
Boursi, Ben
Jacobson, Galia
Raskin, Stephen
Ackerstein, Aliza
Margalit, Ofer
Appel, Sarit
Schvimer, Michael
Crochiere, Marsha
Yang, Fan
Landesman, Yosef
Rashal, Tami
Shacham, Sharon
Golan, Talia
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (02): : 250 - 255
[49] Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
Vinod Vijay Subhash
Mei Shi Yeo
Lingzhi Wang
Shi Hui Tan
Foong Ying Wong
Win Lwin Thuya
Woei Loon Tan
Praveen C. Peethala
Mu Yar Soe
David S. P. Tan
Nisha Padmanabhan
Erkan Baloglu
Sharon Shacham
Patrick Tan
H. Phillip Koeffler
Wei Peng Yong
Scientific Reports, 8
[50] Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
Subhash, Vinod Vijay
Yeo, Mei Shi
Wang, Lingzhi
Tan, Shi Hui
Wong, Foong Ying
Thuya, Win Lwin
Tan, Woei Loon
Peethala, Praveen C.
Soe, Mu Yar
Tan, David S. P.
Padmanabhan, Nisha
Baloglu, Erkan
Shacham, Sharon
Tan, Patrick
Koeffler, H. Phillip
Yong, Wei Peng
SCIENTIFIC REPORTS, 2018, 8

← 1 2 3 4 5 →